Cumberland Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 05/15/2026 | 553.15 K | $1.80 M | -0.50% | 3.70% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 470.70 K | $1.53 M | -0.31% | 3.15% |
| 05/15/2026 | 361.76 K | $1.18 M | 100.00% | 2.42% | |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 276.36 K | $898.17 K | 1.50% | 1.85% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 196.98 K | $640.18 K | -42.25% | 1.32% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 163.47 K | $531.27 K | 0.00% | 1.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 127.69 K | $415.01 K | -0.63% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 114.29 K | $371.50 K | 6.54% | 0.76% |
| J. GOLDMAN & CO LP | 05/15/2026 | 81.04 K | $263.38 K | -14.28% | 0.54% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 58.46 K | $189.99 K | -19.38% | 0.39% |
| BLACKROCK, INC. | 05/13/2026 | 56.89 K | $184.90 K | 8.21% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 56.70 K | $184.28 K | 100.00% | 0.38% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 45.62 K | $148.28 K | 100.00% | 0.31% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 44.29 K | $143.00 K | 0.00% | 0.30% |
| STATE STREET CORP | 05/15/2026 | 39.51 K | $128.41 K | 17.24% | 0.26% |
| MAREX GROUP PLC | 05/13/2026 | 36.42 K | $118.38 K | 100.00% | 0.24% |
| JANE STREET GROUP, LLC | 05/12/2026 | 31.50 K | $102.38 K | 103.23% | 0.21% |
| XTX TOPCO LTD | 05/15/2026 | 24.01 K | $78.02 K | 100.00% | 0.16% |
| CITADEL ADVISORS LLC | 05/15/2026 | 20.60 K | $66.95 K | 48.20% | 0.14% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 20.25 K | $65.82 K | 100.00% | 0.14% |
| NORTHERN TRUST CORP | 05/14/2026 | 19.60 K | $63.71 K | 0.00% | 0.13% |
| CRESSET ASSET MANAGEMENT, LLC | 05/15/2026 | 19.48 K | $63.29 K | 11.44% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 16.80 K | $54.60 K | 20.00% | 0.11% |
| CITADEL ADVISORS LLC | 05/15/2026 | 16.64 K | $54.09 K | -24.20% | 0.11% |
| JANE STREET GROUP, LLC | 05/12/2026 | 14.61 K | $47.47 K | 100.00% | 0.10% |
| JANE STREET GROUP, LLC | 05/12/2026 | 12.80 K | $41.60 K | 100.00% | 0.09% |
| CITADEL ADVISORS LLC | 05/15/2026 | 12.50 K | $40.63 K | -56.90% | 0.08% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 11.09 K | $36.03 K | -54.73% | 0.07% |
| UBS GROUP AG | 05/05/2026 | 5.19 K | $16.86 K | -66.27% | 0.03% |
| MORGAN STANLEY | 05/15/2026 | 3.26 K | $10.60 K | 0.00% | 0.02% |
| CAPITAL ADVISORS, LTD. LLC | 04/16/2026 | 437 | $1.00 K | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 100 | $325 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 2 | $6 | 100.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 05/15/2026 | 1 | $3 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| HERON BAY CAPITAL MANAGEMENT | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Cumberland Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 553,153
RENAISSANCE TECHNOLOGIES LLC: 470,696
DIMENSIONAL FUND ADVISORS LP: 276,359
PERCEPTIVE ADVISORS LLC: 196,978
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 163,468
BOOTHBAY FUND MANAGEMENT, LLC: 127,694
18.46% of Cumberland Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.39 M shares in the last 24 months. This purchase volume represents approximately $11.55 M in transactions.